MicroRNA 1302-8 (MIR1302-8)

MicroRNA 1302-8 (MIR1302-8) is a member of the human miRNA family; miRNAs are short (20–24 nucleotides), non-coding RNA molecules involved in post-transcriptional regulation of gene expression. MIR1302-8, specifically, is transcribed as part of a larger precursor and processed by enzymes (Drosha, Dicer) to form a mature miRNA, which participates in gene silencing via the RNA-induced silencing complex (RISC)[1]. The MIR1302 family is derived from MER53 transposable elements, seen predominantly in placental mammals, and its evolutionary history suggests segmental duplication and transposon-mediated expansion[2]. While the general miRNA function is broadly described, the biological function and disease relevance of MIR1302-8 specifically remain uncharacterized, with no known direct disease associations, drug interactions, or validated use as a biomarker or therapeutic target[2][1]. The gene is recognized by genomic and miRNA databases, but current literature does not cite experiment-based functional or clinical applications for MIR1302-8. If you require disease-specific evidence or potential regulatory pathways involving MIR1302-8, further experimental validation or broader family-level studies will be necessary, as this particular miRNA has limited functional annotation and no recognized clinical utility at present[2][1].

Other names

hsa-mir-1302-8MIRN1302-8MIR1302-8